Kane Biotech Announces Second Quarter 2026 Financial Results

WINNIPEG, Manitoba, Aug. 27, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its second quarter 2026 financial results. Second Quarter 2026 Financial Highlights: Total revenue for the three months ended June 30, 2026 was $8,143 compared to $27,997 for the three months ended June 30, 2025. Revenue […]